Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1096 of 1,261
  1. US 7150871

    Treatment of acute lung injury, fibrosis and metastasis with antagonists of Ξ±vΞ²6

    The Regents of the University of California Β· Granted Dec 19, 2006 Β· Expires Dec 14, 2026

    granted
  2. US 7150984

    Attenuated human rotavirus vaccine

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 19, 2006 Β· Expires Dec 14, 2026

    granted
  3. US 7151087

    CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

    The United States of America as represented by the Department of Health and Human Resources Β· Granted Dec 19, 2006 Β· Expires Dec 14, 2026

    granted
  4. US 7150766

    Method of particle formation

    Nektar Therapeutics UK, Ltd Β· Granted Dec 19, 2006 Β· Expires Dec 14, 2026

    granted
  5. US 7151101

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated Β· Granted Dec 19, 2006 Β· Expires Dec 14, 2026

    granted
  6. US 7150869

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR Β· Granted Dec 19, 2006 Β· Expires Dec 14, 2026

    granted
  7. US 7148197

    Orally administered small peptides synergize statin activity

    The Regents of the University of California Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  8. US 7148196

    Anticancer compounds and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  9. US 7147806

    Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

    Aphios Corporation Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  10. US 7148251

    Amino ceramide-like compounds and therapeutic methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  11. US 7148201

    Use of human plasma hyaluronidase in cancer treatment

    The Regents of the University of California Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  12. US 7148323

    Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  13. US 7148376

    Polymorphic forms of nateglinide

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  14. US 7148036

    DNA molecules encoding cartilage-derived morphogenetic proteins

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  15. US 7147863

    UVA (> 360-400) and UVB (300-325) specific sunscreens

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  16. US 7148193

    Compounds that bind to growth hormone receptor

    ANTYRA INC. Β· Granted Dec 12, 2006 Β· Expires Dec 7, 2026

    granted
  17. US 7144723

    Marine actinomycete taxon for drug and fermentation product discovery

    The Regents of the University of California Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  18. US 7144986

    Polypeptides comprising IL-6 ligand binding receptor domains

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  19. US 7144900

    Pharmaceutical composition

    Takeda Pharmaceutical Company Limited Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  20. US 7144916

    Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  21. US 7144867

    Anticancer glycoside compounds

    Northwestern University Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  22. US 7144862

    Orally administered peptides to ameliorate atherosclerosis

    The Regents of the University of California Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  23. US 7144880

    Compositions relating to novel compounds and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted
  24. US 7144875

    Methods of treating fungal infections using lupeol

    Regents of the University of Minnesota Β· Granted Dec 5, 2006 Β· Expires Nov 30, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.